Muzi.com News Gallery Library Forum Celebrity Movies Chinastar Regions Channels
Set Home|Subscribe|Premium Home|MyMuzi

Home | Headlines | Photos | Region | People | Time | Events | Business | Sports | Showbiz | IT | Politics | Military | Society | Education | Life | Health | Most-viewed Story | Most-viewed Coverage
  Muzi.com : Muzi (English) : News
  Blue chips rise; S&P logs best week since '03
Last updated: 2007-03-23


Blue chips rise; S&P logs best week since '03
2007-03-23

Category
Mortgage Lender
Event
U.S. Markets
Company
Amgen Inc
ImClone Systems Inc.
Chevron Corp
ExxonMobil
General Motors
U.S. blue chips inched up on Friday, capping a rally in which the S&P 500 logged its biggest weekly gain since 2003 on speculation that the Federal Reserve's next move will be an interest rate cut.

The Dow and the S&P were buoyed by a jump in General Motors Corp. shares on speculation that the automaker will not bid for Chrysler and by a gain in energy shares after crude oil futures climbed on a new diplomatic crisis involving Iran.

Stocks had their best day on Wednesday when the Fed left interest rates unchanged and dropped language about possible rate increases, fanning speculation about a cut.

"At this point, everyone assumes the rate cut is coming, so anything that suggests inflation will do some damage," said Joe Saluzzi co-manager of trading at Themis Trading in Chatham, New Jersey. "We're in a fine balancing act between economic growth and inflation."

The Dow Jones industrial average closed up 19.87 points, or 0.16 percent, at 12,481.01. The Standard & Poor's 500 Index finished up 1.57 points, or 0.11 percent, at 1,436.11. The Nasdaq Composite Index finished down 2.81 points, or 0.11 percent, at 2,448.93.

The Nasdaq Stock Market Inc. corrected the closing value for its Composite Index to fix erroneous trades, making the index lower on the day, not higher as originally indicated, a spokesman said.

The Dow finished the week up 3.1 percent and the Nasdaq gained 3.2 percent. The S&P added 3.5 percent, its biggest rise since March 2003.

Despite the strong performance on the week, trading was light, suggesting investors may lack conviction about the market's strength.

Dragging down the Nasdaq were shares of Amgen Inc., which fell after the world's largest biotechnology company canceled a clinical trial involving a colon cancer drug.

Amgen shares dropped 4.1 percent, or $2.45, to $58.02 on the Nasdaq. Shares of ImClone, which makes a competing drug, rose 13.6 percent, or $4.62, to $38.50 on the New York Stock Exchange.

Oil prices rose after Iranian forces seized 15 British Royal Navy sailors and marines on Friday, sparking a diplomatic crisis. Crude futures gained 59 cents to settle at $62.28 a barrel while gasoline futures jumped to a seven-month high, hitting $2.

Higher energy prices increase companies' cost of doing business, while higher gasoline prices squeeze consumers' discretionary income, threatening a drag on corporate profits.

But the rise in oil prices lifted oil company stocks. Shares of Exxon Mobil Corp., another Dow constituent, rose 0.8 percent, or 62 cents, to $74.98 on the New York Stock Exchange. Shares of Chevron Corp. climbed 1.1 percent, or 77 cents, to $73.70 on the NYSE.

GM shares jumped 5.5 percent, or $1.67, to $31.99 as investors speculated that the automaker would be less likely to buy Chrysler. Two private equity firms and Canadian auto parts supplier Magna International Inc. have emerged as the leading candidates for buyers.

Stocks briefly jumped on a report showing an unexpected rise in existing-home sales last month but pared those gains after investors noted that prices have stagnated and the inventory of unsold homes has increased.

The National Association of Realtors reported that existing-home sales increased by a stronger-than-expected 3.9 percent to a 6.69 million-unit annual rate as mild weather spurred home buying. Inventories of unsold homes on the market rose 5.9 percent to 3.748 million units.

Investors are eager for signs of stability in housing following recent turmoil in the subprime mortgage sector, which makes loans to people with weak credit or low income.

Friday's volume was the weakest of the week, with about 1.4 billion shares changing hands on the NYSE -- well below last year's estimated daily average of 1.84 billion. On Nasdaq, about 1.7 billion shares traded, also below last year's daily average of 2.02 billion.

Advancing stocks outnumbered decliners by a ratio of about 4 to 3 on the NYSE and by about 9 to 8 on Nasdaq.

 ImClone Systems Inc.   U.S. Markets 
  Profile2 News8GalleryLinks  
  Lilly to post 2008 loss on ImClone costs (2008-12-11)
  Improving the Use of Drugs Through Genes (2008-10-27)
  Eli Lilly agrees to buy ImClone for over $6B (2008-10-06)
  Blue chips rise; S&P logs best week since '03 (2007-03-23)
  Amgen shares fall on drug setbacks (2007-01-26)
  Bristol-Myers reports loss, hurt by special charges (2007-01-25)
  Glaxo signs record $2.1 bln deal for Genmab drug (2006-12-19)
  ImClone chairman hits back at Icahn as tempers rise (2006-09-21)


Stories Coverages

NewsGuide EventCityPeopleShowCompany 
 ENTSportsBIZEDULifeMilitaryPoliticsSocietyHealth 
[2009 Flight 253 Terrorism Plot]: Airline passengers see tighter security (21:38 12/27)

[2009 Christmas]: Merry Xmas in Hollywood: Box-office record falls (21:38 12/27)


[2009 Fort Hood Shootings]: Airliner plot raises fears about al-Qaida in Yemen (21:38 12/27)


[2009 US Health Reform]: House backers of public insurance option may yield (21:38 12/27)


[111th Congress]: House backers of public insurance option may yield (21:38 12/27)


[SARS in China]: China SARS victims suffer hormone treatment effects: report (21:38 12/27)


[2009 Swine Flu]: 'Rapidly fatal' swine flu kills in different ways: study (21:38 12/27)


[2009 US Tax Crackdown]: UBS whistleblower seeks prison postponement (21:38 12/27)

[U.S. Markets]: Stocks to wrap up 2009 on high note (21:38 12/27)


[Allen Stanford Fraud Case]: Feds investigating Stanford ties to lawmakers: report (21:38 12/27)



Muzi.com

Muzi.com : About | Sitemap | Ads | Contact
All Rights Reserved 1994-2006 - All rights reserved.